Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2005 by Bayside Health.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Bayside Health

ClinicalTrials.gov Identifier:

NCT00157144

First received: September 9, 2005

Last updated: February 27, 2006

Last verified: September 2005

History of Changes

Tracking Information

First Received Date ^ICMJE

September 9, 2005

Last Updated Date

February 27, 2006

Start Date ^ICMJE

Not Provided

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00157144 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

Official Title ^ICMJE

Not Provided

Brief Summary

Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical settings in the adult population without evidence or guidelines to support this practice.

This study involves a nationwide questionnaire which has two components. The initial pilot survey will attempt to identify all institutions currently practicing ECMO or those intending to do so in the future, and are willing to participate in prospective data collection. The second phase will involve a monthly survey of these centres regarding the extent of ECMO use, practice details implemented, and outcome data.

It is hoped that the collection of this information will later assist in the development of guidelines for this expensive and presently unsubstantiated practice, together with the construction of appropriate training programs for staff.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Retrospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Not Provided

Study Population

Not Provided

Condition ^ICMJE

Respiratory Distress Syndrome, Adult
Respiratory Insufficiency
Shock, Cardiogenic

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Patients receiving ECMO in Australia and New Zealand

Gender

Both

Ages

16 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact: Vincent A Pellegrino, MBBS

+61 3 92763036 ext 2606

v.pelligrino@alfred.org.au

Location Countries ^ICMJE

Australia

Administrative Information

NCT Number ^ICMJE

NCT00157144

Other Study ID Numbers ^ICMJE

186/04

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Bayside Health

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Vincent A Pellegrino, MBBS

National Health and Medical Research Council, Australia

Information Provided By

Bayside Health

Verification Date

September 2005

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top